nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—Allergic cutaneous angiitis—Methotrexate—lymphatic system cancer	0.0421	0.0421	CcSEcCtD
Terbutaline—Injection site pain—Carmustine—lymphatic system cancer	0.0354	0.0354	CcSEcCtD
Terbutaline—Sweating—Teniposide—lymphatic system cancer	0.0275	0.0275	CcSEcCtD
Terbutaline—Leukocytoclastic vasculitis—Methotrexate—lymphatic system cancer	0.0273	0.0273	CcSEcCtD
Terbutaline—Flushing—Teniposide—lymphatic system cancer	0.0239	0.0239	CcSEcCtD
Terbutaline—Chest pain—Teniposide—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Terbutaline—Tachycardia—Teniposide—lymphatic system cancer	0.0179	0.0179	CcSEcCtD
Terbutaline—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0177	0.0177	CcSEcCtD
Terbutaline—Dyspnoea—Teniposide—lymphatic system cancer	0.0163	0.0163	CcSEcCtD
Terbutaline—Vomiting—Mechlorethamine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Terbutaline—Rash—Mechlorethamine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Terbutaline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Terbutaline—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Terbutaline—Flushing—Bleomycin—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Terbutaline—Drowsiness—Mitoxantrone—lymphatic system cancer	0.015	0.015	CcSEcCtD
Terbutaline—Sweating—Vincristine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Terbutaline—Nausea—Mechlorethamine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Terbutaline—Paraesthesia—Fludarabine—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Terbutaline—Hallucination—Carmustine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Terbutaline—Sweating—Mitoxantrone—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Terbutaline—Dyspnoea—Fludarabine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Terbutaline—Hallucination—Vincristine—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Terbutaline—Flushing—Carmustine—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Terbutaline—Asthenia—Teniposide—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Terbutaline—Chest pain—Bleomycin—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Terbutaline—Tremor—Carmustine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Terbutaline—Vomiting—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Terbutaline—Asthenia—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Terbutaline—Rash—Teniposide—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Terbutaline—Dermatitis—Teniposide—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Terbutaline—Headache—Teniposide—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Terbutaline—Nausea—Teniposide—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Terbutaline—Chest pain—Carmustine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Terbutaline—Anxiety—Carmustine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Terbutaline—Paraesthesia—Bleomycin—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Terbutaline—Dyspnoea—Bleomycin—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Terbutaline—Vomiting—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Terbutaline—Rash—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Terbutaline—Dermatitis—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Terbutaline—Headache—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Terbutaline—Tachycardia—Carmustine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Terbutaline—Chest pain—Mitoxantrone—lymphatic system cancer	0.01	0.01	CcSEcCtD
Terbutaline—Anxiety—Mitoxantrone—lymphatic system cancer	0.00996	0.00996	CcSEcCtD
Terbutaline—Nausea—Fludarabine—lymphatic system cancer	0.00957	0.00957	CcSEcCtD
Terbutaline—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00951	0.00951	CcSEcCtD
Terbutaline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00935	0.00935	CcSEcCtD
Terbutaline—Insomnia—Carmustine—lymphatic system cancer	0.00932	0.00932	CcSEcCtD
Terbutaline—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00926	0.00926	CcSEcCtD
Terbutaline—Paraesthesia—Carmustine—lymphatic system cancer	0.00925	0.00925	CcSEcCtD
Terbutaline—Dyspnoea—Carmustine—lymphatic system cancer	0.00919	0.00919	CcSEcCtD
Terbutaline—Somnolence—Carmustine—lymphatic system cancer	0.00916	0.00916	CcSEcCtD
Terbutaline—Insomnia—Vincristine—lymphatic system cancer	0.0089	0.0089	CcSEcCtD
Terbutaline—Paraesthesia—Vincristine—lymphatic system cancer	0.00883	0.00883	CcSEcCtD
Terbutaline—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.0086	0.0086	CcSEcCtD
Terbutaline—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00854	0.00854	CcSEcCtD
Terbutaline—Somnolence—Mitoxantrone—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Terbutaline—Asthenia—Bleomycin—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Terbutaline—Vomiting—Bleomycin—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Terbutaline—Drowsiness—Methotrexate—lymphatic system cancer	0.00749	0.00749	CcSEcCtD
Terbutaline—Rash—Bleomycin—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Terbutaline—Dermatitis—Bleomycin—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Terbutaline—Asthenia—Carmustine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Terbutaline—Sweating—Methotrexate—lymphatic system cancer	0.00718	0.00718	CcSEcCtD
Terbutaline—Asthenia—Vincristine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Terbutaline—Nausea—Bleomycin—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Terbutaline—Asthenia—Mitoxantrone—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Terbutaline—Dizziness—Carmustine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Terbutaline—Vomiting—Carmustine—lymphatic system cancer	0.00655	0.00655	CcSEcCtD
Terbutaline—Dizziness—Vincristine—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Terbutaline—Rash—Carmustine—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Terbutaline—Dermatitis—Carmustine—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Terbutaline—Headache—Carmustine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Terbutaline—Vomiting—Vincristine—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Terbutaline—Rash—Vincristine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Terbutaline—Dermatitis—Vincristine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Terbutaline—Headache—Vincristine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Terbutaline—Nausea—Carmustine—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Terbutaline—Vomiting—Mitoxantrone—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Terbutaline—Rash—Mitoxantrone—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Terbutaline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Terbutaline—Headache—Mitoxantrone—lymphatic system cancer	0.006	0.006	CcSEcCtD
Terbutaline—Nausea—Vincristine—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Terbutaline—Nausea—Mitoxantrone—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Terbutaline—Chest pain—Methotrexate—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Terbutaline—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Terbutaline—Insomnia—Methotrexate—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Terbutaline—Paraesthesia—Methotrexate—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Terbutaline—Dyspnoea—Methotrexate—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Terbutaline—Somnolence—Methotrexate—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Terbutaline—Asthenia—Methotrexate—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Terbutaline—Dizziness—Methotrexate—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Terbutaline—Vomiting—Methotrexate—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Terbutaline—Rash—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Terbutaline—Dermatitis—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Terbutaline—Headache—Methotrexate—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Terbutaline—Nausea—Methotrexate—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
